CLN-13570-23511
2 vaccinations
4 coded responses
10 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 544 / WI
- Registered
- 2021-12-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-23
Dose 1 — Pfizer-BioNTech
-
2021-12-01
Registered in v-safe
- 2021-12-01
- 2021-12-09
-
2021-12-14
Dose 2 — Pfizer-BioNTech
-
2021-12-14
Survey response — day 0, dose 2MedDRA: Intermenstrual bleeding — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Potential disruption of normal menses. Had increased days of spotting after 1st doseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-21
- 2021-12-30
-
2022-01-04
Survey response — day 21, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Weakness and nausea from pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
-
2022-01-18
Survey response — day 35, dose 2MedDRA: Pain — Feeling: FairFree text: Sore body could be from a massage i had completed yesterday or from travelMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Survey response — day 42, dose 2MedDRA: Abortion spontaneous, Foetal cardiac disorder, Ultrasound foetal abnormal, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Miscarriage at 9 weeks and 6 days. No cardiac activity at ultrasound. LMP was 11/16. Very concerned that the vaccine could have caused this miscarriage since the doses were so early in pregnancy. · Healthcare visit (other): Scheduled D&CMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-26
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-23 | Pfizer-BioNTech | No |
| 2 | 2021-12-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-25 | Successful 2022-01-26 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — day 0, dose 2
Systemic reaction (other): Potential disruption of normal menses. Had increased days of spotting after 1st dose
Release 10 — day 21, dose 2
Symptoms: Weakness and nausea from pregnancy
Release 10 — day 35, dose 2
Symptoms: Sore body could be from a massage i had completed yesterday or from travel
Release 11 — day 42, dose 2
Symptoms: Miscarriage at 9 weeks and 6 days. No cardiac activity at ultrasound. LMP was 11/16. Very concerned that the vaccine could have caused this miscarriage since the doses were so early in pregnancy.
Healthcare visit (other): Scheduled D&C
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Foetal cardiac disorder | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Ultrasound foetal abnormal | · | · | ✓ |
| SRO | Intermenstrual bleeding | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release